After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
Marc Stapley, CEO of the genomic diagnostics company Veracyte (NASDAQ:VCYT), is enthusiastic about Rebecca Chambers, the new Chief Financial Officer (CFO), who started her role on July 19.
Stapley said he “can think of no one more qualified to lead our…
